PL2851428T3 - Szczepionki i diagnostyka świńskiego wirusa Torque teno - Google Patents

Szczepionki i diagnostyka świńskiego wirusa Torque teno

Info

Publication number
PL2851428T3
PL2851428T3 PL14180718T PL14180718T PL2851428T3 PL 2851428 T3 PL2851428 T3 PL 2851428T3 PL 14180718 T PL14180718 T PL 14180718T PL 14180718 T PL14180718 T PL 14180718T PL 2851428 T3 PL2851428 T3 PL 2851428T3
Authority
PL
Poland
Prior art keywords
diagnosis
virus vaccines
torque teno
teno virus
porcine torque
Prior art date
Application number
PL14180718T
Other languages
English (en)
Inventor
Xiang-Jin Meng
Yaowei Huang
Original Assignee
Virginia Tech Intellectual Properties, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virginia Tech Intellectual Properties, Inc. filed Critical Virginia Tech Intellectual Properties, Inc.
Publication of PL2851428T3 publication Critical patent/PL2851428T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/00021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/00022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/00034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/085—Picornaviridae, e.g. coxsackie virus, echovirus, enterovirus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Analytical Chemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
PL14180718T 2009-08-21 2010-08-23 Szczepionki i diagnostyka świńskiego wirusa Torque teno PL2851428T3 (pl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US23583309P 2009-08-21 2009-08-21
US31651910P 2010-03-23 2010-03-23
EP10815817.1A EP2467484A4 (en) 2009-08-21 2010-08-23 DIAGNOSIS OF TORQUE TENO VIRUS IN PIGS AND VACCINATE THEREOF
EP14180718.0A EP2851428B1 (en) 2009-08-21 2010-08-23 Porcine torque teno virus vaccines and diagnosis
PCT/US2010/046330 WO2011031438A2 (en) 2009-08-21 2010-08-23 Porcine torque teno virus vaccines and diagnosis
US12/861,378 US9228242B2 (en) 2009-08-21 2010-08-23 Porcine torque teno virus vaccines and diagnosis

Publications (1)

Publication Number Publication Date
PL2851428T3 true PL2851428T3 (pl) 2019-12-31

Family

ID=43605547

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14180718T PL2851428T3 (pl) 2009-08-21 2010-08-23 Szczepionki i diagnostyka świńskiego wirusa Torque teno

Country Status (19)

Country Link
US (2) US9228242B2 (pl)
EP (2) EP2851428B1 (pl)
JP (3) JP6002036B2 (pl)
KR (3) KR101721090B1 (pl)
CN (2) CN107522775A (pl)
AU (1) AU2010292848B2 (pl)
BR (1) BR112012003844B1 (pl)
CA (1) CA2771771C (pl)
CL (4) CL2012000452A1 (pl)
CO (1) CO6531416A2 (pl)
ES (1) ES2767781T3 (pl)
HK (1) HK1249111A1 (pl)
IN (1) IN2012DN02305A (pl)
MX (1) MX344015B (pl)
PL (1) PL2851428T3 (pl)
RU (1) RU2553223C2 (pl)
SG (1) SG178512A1 (pl)
WO (1) WO2011031438A2 (pl)
ZA (1) ZA201201949B (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2851428B1 (en) 2009-08-21 2019-04-10 Virginia Tech Intellectual Properties, Inc. Porcine torque teno virus vaccines and diagnosis
EP2530170A1 (en) * 2011-05-31 2012-12-05 Intervet International BV Torque Teno virus diagnostics
CN102590503B (zh) * 2012-01-20 2015-02-25 四川农业大学 一种猪细环病毒ⅱ型抗体间接阻断elisa检测试剂盒
CN103376317B (zh) * 2012-04-12 2015-11-18 徐超 不同疫苗适用性与经济性的现场判定方法
EP2653562A1 (en) * 2012-04-20 2013-10-23 Institut Pasteur Anellovirus genome quantification as a biomarker of immune suppression
CN102998453B (zh) * 2012-11-23 2014-10-08 广东海大畜牧兽医研究院有限公司 一种猪Ⅰ型细环病毒TTSuV1抗体间接ELISA诊断试剂盒及其制备方法
CN103014056B (zh) * 2012-11-23 2014-12-10 广东海大畜牧兽医研究院有限公司 一种猪Ⅱ型细环病毒TTSuV2-ORF1截短蛋白的酵母表达及应用
CN103235121B (zh) * 2013-03-18 2015-08-05 江苏省农业科学院 一种检测猪输血传播病毒2型抗体的间接elisa试剂盒
RU2771533C2 (ru) * 2015-10-16 2022-05-05 Канзас Стейт Юниверсити Рисерч Фаундейшн Иммуногенные композиции для иммунизации свиней против цирковируса типа 3 и способы их получения и применения
CN107604098A (zh) * 2017-11-03 2018-01-19 福建省农业科学院畜牧兽医研究所 用于检测鸽TTV的EvaGreen实时荧光定量PCR引物及试剂盒
CN109061161B (zh) * 2018-11-14 2019-02-15 湖南省植物保护研究所 用于检测辣椒脉黄病毒的检测试剂盒及其应用
US20230348933A1 (en) * 2020-06-12 2023-11-02 Flagship Pioneering Innovations V, Inc. Tandem anellovirus constructs
EP4267157A1 (en) * 2020-12-23 2023-11-01 Flagship Pioneering Innovations V, Inc. In vitro assembly of anellovirus capsids enclosing rna

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1061377C (zh) * 1996-12-13 2001-01-31 中国预防医学科学院病毒学研究所 能用于包装重组腺病毒伴随病毒的单疱病毒载体及其用途
CN1704119A (zh) * 2004-05-28 2005-12-07 上海佳牧生物制品有限公司 猪细小病毒病油乳剂灭活疫苗
WO2008150275A2 (en) * 2006-10-05 2008-12-11 Cerebus Biologicals, Inc. Methods for preventing and ameiliorating porcine respiratory and reproductive syndrome virus-associated disease by immunizing against porcine ttv infection
JP2012505653A (ja) * 2008-10-16 2012-03-08 ファイザー・インク トルクテノウイルス（ＴｏｒｑｕｅＴｅｎｏＶｉｒｕｓｕ：ＴＴＶ）単離株および組成物
EP2851428B1 (en) 2009-08-21 2019-04-10 Virginia Tech Intellectual Properties, Inc. Porcine torque teno virus vaccines and diagnosis

Also Published As

Publication number Publication date
BR112012003844B1 (pt) 2021-05-04
CA2771771A1 (en) 2011-03-17
EP2851428A2 (en) 2015-03-25
EP2467484A2 (en) 2012-06-27
US20160216263A1 (en) 2016-07-28
KR101640062B1 (ko) 2016-07-18
JP2015221819A (ja) 2015-12-10
US20110045019A1 (en) 2011-02-24
KR20140127903A (ko) 2014-11-04
WO2011031438A2 (en) 2011-03-17
KR20140110101A (ko) 2014-09-16
CN102712930A (zh) 2012-10-03
MX344015B (es) 2016-12-02
CA2771771C (en) 2018-09-11
CN102712930B (zh) 2017-06-13
JP2017171663A (ja) 2017-09-28
EP2467484A4 (en) 2013-06-12
RU2012110303A (ru) 2013-09-27
WO2011031438A9 (en) 2011-08-18
IN2012DN02305A (pl) 2015-08-21
JP2013502229A (ja) 2013-01-24
KR101721090B1 (ko) 2017-03-29
ES2767781T3 (es) 2020-06-18
ZA201201949B (en) 2013-05-29
WO2011031438A3 (en) 2011-06-30
BR112012003844A2 (pt) 2016-11-16
US9228242B2 (en) 2016-01-05
CO6531416A2 (es) 2012-09-28
CN107522775A (zh) 2017-12-29
HK1249111A1 (zh) 2018-10-26
CL2014003561A1 (es) 2015-04-24
MX2012002273A (es) 2012-09-07
KR20120063489A (ko) 2012-06-15
US9897605B2 (en) 2018-02-20
CL2014003563A1 (es) 2015-04-17
RU2553223C2 (ru) 2015-06-10
EP2851428B1 (en) 2019-04-10
SG178512A1 (en) 2012-03-29
CL2014003562A1 (es) 2015-04-24
AU2010292848A1 (en) 2012-04-12
JP6002036B2 (ja) 2016-10-05
EP2851428A3 (en) 2015-04-29
CL2012000452A1 (es) 2013-07-05
AU2010292848B2 (en) 2014-11-27
JP6126176B2 (ja) 2017-05-10

Similar Documents

Publication Publication Date Title
HK1249111A1 (zh) 豬細環病毒的疫苗和診斷
GB2494493B (en) Patient interface and aspects thereof
GB2482092B (en) Patient interface and aspects thereof
HK1167107A1 (en) Vaccine composition comprising 5-cap modified rna 5-cap rna
IL215389A0 (en) Pneumococcal vaccine and uses thereof
ZA201204050B (en) Vaccination syringe
EP2552479A4 (en) INFLUENZA VIRUS VACCINES AND USES THEREOF
HK1144787A1 (en) Anti-fmd vaccine composition and preparation and use thereof
PT2393496T (pt) Vacinas melhoradas para vírus do papiloma humano e métodos para utilização das mesmas
SG10201503450WA (en) Vaccine against beta-herpesvirus infection and use thereof
EP2416801A4 (en) IMMUNOGENIC COMPOSITION AND ITS USES
EP2429577A4 (en) NEW HUMAN ROTAVIRENSTÄMME AND VACCINES
GB201005625D0 (en) Immunogenic proteins and compositions
EP2285405A4 (en) VACCINE COMPOSITIONS AND METHODS
EP2484378A4 (en) VACCINE COMPOSITION AGAINST HEPATITIS C VIRUS
GB201103423D0 (en) Immunogenic proteins and compositions
EP2581099A4 (en) MEDICAL DEVICE FOR INTERVENTION AND PREPARATION THEREOF
ZA201203412B (en) Anti-trypanosomiasis vaccines and diagnostics
EP2507263A4 (en) ANTI-IGF-IR ANTIBODIES AND ITS USES
GB0907935D0 (en) Vaccines
ZA201100889B (en) Vaccine against hpv
EP2430039A4 (en) TTK-PEPTIDES AND VACCINES CONTAINING THEM
GB2467215B (en) Burkholderia components vaccine
EP2411039A4 (en) Glycoconjugate VACCINES
EP2453916A4 (en) SUPRALINGUAL VACCINES AND SUPRALINGUAL APPLICATORS